Skip to main content
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie 2/2020

06.05.2020 | Schwerpunkt

His-Purkinje conduction system pacing and atrioventricular node ablation

verfasst von: Amal Muthumala, MD FRCP, Pugazhendhi Vijayaraman, MD FHRS

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

His-Purkinje conduction system pacing (HPCSP) in the form of His bundle pacing and left bundle branch pacing allows normal ventricular activation, thereby preventing the adverse consequences of right ventricular pacing. One potential area where HPCSP could be used is in the field of atrioventricular (AV) node ablation in patients with atrial fibrillation refractory to medical therapy and/or catheter ablation. His bundle pacing has been established for several years, with centres from North America, Europe and China publishing their experience. The differing patterns of His bundle capture are clearly described with established guidance as to how to implant such systems. Left bundle branch pacing has only recently been reported, but there are several advantages with better pacing parameters and lower risk of threshold change after AV node ablation. Six studies have been identified in the literature which describe the experience of His bundle pacing in patients requiring AV node ablation. Overall the results are positive and favour this new technique; however, they are limited by low numbers of patients and non-randomised study design. An observational study was recently published demonstrating better outcomes with left bundle branch pacing in a small number of patients with left ventricular dysfunction and atrial fibrillation that underwent AV node ablation. HPCSP has the potential to be the primary pacing modality in patients with atrial fibrillation requiring AV node ablation. However, it is essential that this is confirmed in large randomised clinical trials.
Literatur
1.
Zurück zum Zitat Deshmukh P, Casavant DA, Romanyshyn M, Anderson K (2000) Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation 101(8):869–867CrossRef Deshmukh P, Casavant DA, Romanyshyn M, Anderson K (2000) Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation 101(8):869–867CrossRef
2.
Zurück zum Zitat Kronborg MB, Mortensen PT, Poulsen SH, Gerdes JC, Jensen HK, Nielsen JC (2014) His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace 16(8):1189–1196CrossRef Kronborg MB, Mortensen PT, Poulsen SH, Gerdes JC, Jensen HK, Nielsen JC (2014) His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace 16(8):1189–1196CrossRef
3.
Zurück zum Zitat Sharma PS, Dandamudi G, Naperkowski A, Oren JW, Storm RH, Ellenbogen KA et al (2015) Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm 12(2):305–312CrossRef Sharma PS, Dandamudi G, Naperkowski A, Oren JW, Storm RH, Ellenbogen KA et al (2015) Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm 12(2):305–312CrossRef
4.
Zurück zum Zitat Zanon F, Svetlich C, Occhetta E, Catanzariti D, Cantù F, Padeletti L et al (2011) Safety and performance of a system specifically designed for selective site pacing. Pacing Clin Electrophysiol 34(3):339–347CrossRef Zanon F, Svetlich C, Occhetta E, Catanzariti D, Cantù F, Padeletti L et al (2011) Safety and performance of a system specifically designed for selective site pacing. Pacing Clin Electrophysiol 34(3):339–347CrossRef
5.
Zurück zum Zitat Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X et al (2017) Benefits of permanent His bundle pacing combined with Atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction. J Am Heart Assoc 6(4):pii:e005309. https://doi.org/10.1161/JAHA.116.005309 CrossRef Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X et al (2017) Benefits of permanent His bundle pacing combined with Atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction. J Am Heart Assoc 6(4):pii:e005309. https://​doi.​org/​10.​1161/​JAHA.​116.​005309 CrossRef
6.
Zurück zum Zitat Beer D, Sharma PS, Subzposh FA, Naperkowski A, Pietrasik GM, Durr B et al (2019) Clinical outcomes of selective versus nonselective His bundle pacing. JACC Clin Electrophysiol 5(7):766–774CrossRef Beer D, Sharma PS, Subzposh FA, Naperkowski A, Pietrasik GM, Durr B et al (2019) Clinical outcomes of selective versus nonselective His bundle pacing. JACC Clin Electrophysiol 5(7):766–774CrossRef
7.
Zurück zum Zitat Upadhyay GA, Tung R (2017) Selective versus non-selective his bundle pacing for cardiac resynchronization therapy. J Electrocardiol 50(2):191–194CrossRef Upadhyay GA, Tung R (2017) Selective versus non-selective his bundle pacing for cardiac resynchronization therapy. J Electrocardiol 50(2):191–194CrossRef
9.
Zurück zum Zitat Vijayaraman P, Dandamudi G, Zanon F, Sharma P, Tung R, Huang W et al (2018) Permanent His Bundle Pacing (HBP): recommendations from a Multi-Center HBP Collaborative Working Group For Standardization Of Definitions, Implant Measurements And Follow-Up. Heart Rhythm 15(3):460–468CrossRef Vijayaraman P, Dandamudi G, Zanon F, Sharma P, Tung R, Huang W et al (2018) Permanent His Bundle Pacing (HBP): recommendations from a Multi-Center HBP Collaborative Working Group For Standardization Of Definitions, Implant Measurements And Follow-Up. Heart Rhythm 15(3):460–468CrossRef
10.
Zurück zum Zitat Vijayaraman P, Chung MK, Dandamudi G, Upadhyay GA, Krishnan K, Crossley G et al (2018) His bundle pacing. J Am Coll Cardiol 72(8):927–947CrossRef Vijayaraman P, Chung MK, Dandamudi G, Upadhyay GA, Krishnan K, Crossley G et al (2018) His bundle pacing. J Am Coll Cardiol 72(8):927–947CrossRef
11.
Zurück zum Zitat Huang W, Chen X, Su L, Wu S, Xia X, Vijayaraman P (2019) A beginner’s guide to permanent left bundle branch pacing. Heart Rhythm 16(12):1791–1796CrossRef Huang W, Chen X, Su L, Wu S, Xia X, Vijayaraman P (2019) A beginner’s guide to permanent left bundle branch pacing. Heart Rhythm 16(12):1791–1796CrossRef
12.
Zurück zum Zitat Vijayaraman P, Subzposh FA, Naperkowski A, Panikkath R, John K, Mascarenhas V et al (2019) Prospective evaluation of feasibility and electrophysiologic and echocardiographic characteristics of left bundle branch area pacing. Heart Rhythm 16(12):1774–1782CrossRef Vijayaraman P, Subzposh FA, Naperkowski A, Panikkath R, John K, Mascarenhas V et al (2019) Prospective evaluation of feasibility and electrophysiologic and echocardiographic characteristics of left bundle branch area pacing. Heart Rhythm 16(12):1774–1782CrossRef
13.
Zurück zum Zitat Wang S, Wu S, Xu L, Xiao F, Whinnett ZI, Vijayaraman P et al (2019) Feasibility and efficacy of His bundle pacing or left bundle pacing combined with atrioventricular node ablation in patients with persistent atrial fibrillation and Implantable cardioverter-defibrillator therapy. J Am Heart Assoc 8(24):e14253CrossRef Wang S, Wu S, Xu L, Xiao F, Whinnett ZI, Vijayaraman P et al (2019) Feasibility and efficacy of His bundle pacing or left bundle pacing combined with atrioventricular node ablation in patients with persistent atrial fibrillation and Implantable cardioverter-defibrillator therapy. J Am Heart Assoc 8(24):e14253CrossRef
14.
Zurück zum Zitat Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG et al (1999) Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial Fibrillation. Europace 1(1):15–19CrossRef Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG et al (1999) Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial Fibrillation. Europace 1(1):15–19CrossRef
15.
Zurück zum Zitat Brignole M, Botto G, Mont L, Iacopino S, De Marchi G, Oddone D et al (2011) Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J 32(19):2420–2429CrossRef Brignole M, Botto G, Mont L, Iacopino S, De Marchi G, Oddone D et al (2011) Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J 32(19):2420–2429CrossRef
16.
Zurück zum Zitat Burri H, Keene D, Whinnett Z, Zanon F, Vijayaraman P (2019) Device programming for His bundle pacing. Circ Arrhythm Electrophysiol 12(2):e6816CrossRef Burri H, Keene D, Whinnett Z, Zanon F, Vijayaraman P (2019) Device programming for His bundle pacing. Circ Arrhythm Electrophysiol 12(2):e6816CrossRef
17.
Zurück zum Zitat Deshmukh PM, Romanyshyn M (2004) Direct His-bundle pacing: present and future. Pacing Clin Electrophysiol 27(6):862–870CrossRef Deshmukh PM, Romanyshyn M (2004) Direct His-bundle pacing: present and future. Pacing Clin Electrophysiol 27(6):862–870CrossRef
18.
Zurück zum Zitat Occhetta E, Bortnik M, Magnani A, Francalacci G, Piccinino C, Plebani L et al (2006) Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol 47(10):1938–1945CrossRef Occhetta E, Bortnik M, Magnani A, Francalacci G, Piccinino C, Plebani L et al (2006) Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol 47(10):1938–1945CrossRef
19.
Zurück zum Zitat Occhetta E, Bortnik M, Marino P (2007) Permanent parahisian pacing. Indian Pacing Electrophysiol J 7(2):110–125PubMedPubMedCentral Occhetta E, Bortnik M, Marino P (2007) Permanent parahisian pacing. Indian Pacing Electrophysiol J 7(2):110–125PubMedPubMedCentral
20.
Zurück zum Zitat Vijayaraman P, Subzposh FA, Naperkowski A (2017) Atrioventricular node ablation and His bundle pacing. Europace 19(suppl_4):iv10–iv16CrossRef Vijayaraman P, Subzposh FA, Naperkowski A (2017) Atrioventricular node ablation and His bundle pacing. Europace 19(suppl_4):iv10–iv16CrossRef
21.
Zurück zum Zitat Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C et al(2019) 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. https://doi.org/10.1093/eurheartj/ehz467 CrossRefPubMed Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C et al(2019) 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. https://​doi.​org/​10.​1093/​eurheartj/​ehz467 CrossRefPubMed
Metadaten
Titel
His-Purkinje conduction system pacing and atrioventricular node ablation
verfasst von
Amal Muthumala, MD FRCP
Pugazhendhi Vijayaraman, MD FHRS
Publikationsdatum
06.05.2020
Verlag
Springer Medizin
Erschienen in
Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 2/2020
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI
https://doi.org/10.1007/s00399-020-00679-7

Weitere Artikel der Ausgabe 2/2020

Herzschrittmachertherapie + Elektrophysiologie 2/2020 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.